Sign in / Join Now
ETFs & Funds
This is non-news! Anyone that thinks it matters is absolutely dumb! The FDA made many mistakes over years w/
, but what can you do?
Add a reply...
Latest StockTalks »
people get BMY breaking news and analysis by email alert.
Get email alerts on BMY »
Bristol-Myers Squibb Company
Get latest price
From other sites
Bristol-Myers Squibb To Announce Results For Fourth Quarter 2016 On January 26, 2017
at TheStreet (Fri, 4:00PM)
Bristol-Myers Squibb Announces Dividend Increase
at TheStreet (Thu, 4:15PM)
Opdivo (nivolumab) Alone Or Combined With Yervoy (ipilimumab) Shows Encouraging Response And Survival Rates In Recurrent Small Cell Lung Cancer, From Phase 1/2 Study CheckMate -032
at TheStreet (Tue, 8:45AM)
Seattle Genetics And Bristol-Myers Squibb Highlight First Data From Phase 1/2 Study Evaluating ADCETRIS® (Brentuximab Vedotin) In Combination With Opdivo (nivolumab) In Relapsed Or Refractory Hodgkin Lymphoma At ASH Annual Meeting
at TheStreet (Mon, 7:30PM)
Encouraging Survival Observed With Opdivo (nivolumab) Plus Yervoy (ipilimumab) With Longer Follow-up In First-line Advanced Non-small Cell Lung Cancer, In Updated Phase 1b CheckMate -012 Study
at TheStreet (Mon, 5:00AM)